| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |